High Tower Advisors, LLC Anavex Life Sciences Corp. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$9.74 - $17.69 $100,107 - $181,817	-10,278 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$16.88 - $23.31 $3,376 - $4,662	-200 Reduced 1.91%	10,278 $178,000
Q3 2021 Nov 12, 2021	BUY	$16.82 - $25.75 $36,213 - $55,439	2,153 Added 25.86%	10,478 $189,000
Q2 2021 Aug 06, 2021	SELL	$10.16 - $28.86 $41,402 - $117,604	-4,075 Reduced 32.86%	8,325 $190,000
Q1 2021 May 10, 2021	BUY	$5.17 - $16.13 $12,408 - $38,712	2,400 Added 24.0%	12,400 $185,000

Q4 2020 Feb 10, 2021	BUY	$4.01 - $7.58 $40,100 - $75,800	10,000 New	10,000 $54,000

160

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $427M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.